Health

Watchdog Highlights Challenges of Medicare Payment Program

Watchdog Highlights Challenges of Medicare Payment Program

Congressional accountability office reviews first three years of value-based health care program.

Vaccine Mandates and Roads Not Taken

Vaccine Mandates and Roads Not Taken

Another regulatory approach to mandate vaccines could have withstood judicial scrutiny.

What It Means to Support a Waiver of COVID-19 Vaccine Patents

What It Means to Support a Waiver of COVID-19 Vaccine Patents

The Biden Administration should exert international and domestic pressure to waive COVID-19 vaccine patents.

Medicare and Chevron in the Supreme Court’s New Term

Medicare and Chevron in the Supreme Court’s New Term

With two Medicare cases, the U.S. Supreme Court may change an important rule on deference to agency decisions.

Taking Hearing Aids Over the Counter

Taking Hearing Aids Over the Counter

FDA proposes a new rule to permit the purchase of hearing aids without a prescription.

Taming Giants in the Health Care Industry

Taming Giants in the Health Care Industry

Scholars explore potential antitrust responses to growing consolidation among health care providers.

Are Artificial Christmas Trees Safe?

Are Artificial Christmas Trees Safe?

Chemicals in artificial Christmas trees may pose health and environmental risks.

Protecting the Right to Express Milk

Protecting the Right to Express Milk

Scholar argues that lactation policies need to do more to protect parents’ rights.

High Hopes for FDA Regulation of CBD Products

High Hopes for FDA Regulation of CBD Products

FDA regulation of CBD products faces new challenges as the market develops.

Vaccinating the Skies

Vaccinating the Skies

Advocates say a vaccine mandate for domestic flights could help keep travelers safe.

Disclosing Gluten in Food

Disclosing Gluten in Food

Pending federal legislation would improve food information for consumers with gluten sensitivity.

Value-Pricing Prescription Drugs

Value-Pricing Prescription Drugs

Scholar argues that reducing pricing for prescription drugs may increase innovation.